Novavax on Thursday swung to a first-quarter profit from a year-ago loss, helped by reduced costs related to the development and sale of its COVID-19 vaccines, its only product on the market.

Officials in sixteen states and the District of Columbia sued in response, leading to Tuesday’s order from U.S. District ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

Senior leaders at the US Food and Drug Administration began pushing Moderna Inc. and Pfizer Inc. to file for full, formal ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...

COVID-19 is the disease caused by SARS-CoV-2, the coronavirus that emerged in December 2019. Coronaviruses are a type of virus. There are many different kinds, and some, like COVID-19, cause disease ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...